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Central arterial wall stiffening, driven by a chronic
inflammatory milieu, accompanies arterial diseases,
the leading cause of cardiovascular (CV) morbidity
and mortality in Western society. An increase in cen-
tral arterial wall stiffening, measured as an increase
in aortic pulse wave velocity (PWV), is a major risk
factor for clinical CV disease events. However, no
specific therapies to reduce PWV are presently
available. In rhesus monkeys, a 2 year diet high
in fat and sucrose (HFS) increases not only body
weight and cholesterol, but also induces prominent
central arterial wall stiffening and increases PWV
and inflammation. The observed loss of endothelial
cell integrity, lipid and macrophage infiltration, and
calcification of the arterial wall were driven by
genomic and proteomic signatures of oxidative
stress and inflammation. Resveratrol prevented the
HFS-induced arterial wall inflammation and the
accompanying increase in PWV. Dietary resveratrolmay hold promise as a therapy to ameliorate in-
creases in PWV.
INTRODUCTION
The incidence of cardiovascular diseases (CVD), mainly arterial
diseases of hypertension and atherosclerosis, increases expo-
nentially beyond middle age (Lakatta, 2013). Stiffening of the
central arteries is a cardinal feature of advancing age in humans
beyond the age of 40 years. Over the last decade numerous
epidemiological and longitudinal studies have convincingly
demonstrated that carotid-femoral pulse wave velocity (PWV),
a direct measure of aortic stiffness, is a highly relevant clinical
measure of arterial stiffness. In humans, an increase in PWV
shows a strong association with CVD-associated clinical events
and all-cause mortality, even after taking other known risk fac-
tors into consideration (Najjar et al., 2008). PWV has emerged
as an independent predictor for CV disease, morbidity, and mor-
tality. There is also strong evidence to indicate that PWV pro-
vides early information about the development/progression of
atherosclerosis before macroscopic alterations of the vesselCell Metabolism 20, 183–190, July 1, 2014 ª2014 Elsevier Inc. 183
Figure 1. Physiological Measurements in Rhesus Monkeys Main-
tained on HFS, HFS+R, or SD Diet for up to 2 Years
(A) Pulse wave velocity.
(B) Blood pressure.
(C) Body weight.
(D) Serum cholesterol levels. Results are mean ± SEM.
See also Table S1.
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of CV events (Reference Values for Arterial Stiffness’ Collabora-
tion, 2010). This epidemiologic perspective suggests that
the reduction of PWV may carry substantial health benefits.
Importantly, metabolic disease in humans accelerates the age-
associated increase in PWV (Scuteri et al., 2012). Histological,
genomic, and proteomic studies provide strong evidence that
increased central arterial stiffness occurs in the context of an
oxidative stress-driven arterial wall inflammatory profile (for re-
view see Wang et al., 2014).
Clinical trials to assess the beneficial effects of pharmacolog-
ical interventions on vascular health have shown that presently
available antiinflammatory drugs, e.g., statins (Williams et al.,
2009) or angiotensin receptor blockers (Hayoz et al., 2012) had
only modest effects, if any, at reducing PWV. Thus, at present,
there are no effective therapies available to reduce PWV, and
novel strategies are required to impact on chronic arterial wall
inflammation and stiffening that underlie and accelerate the pro-
gression of CV diseases, other than classic regulation of blood
pressure. In this regard, vascular protective effects of the
polyphenol resveratrol (Resv) have been illustrated in several
different animal species (Ramprasath and Jones, 2010). Studies
in mice demonstrate that the addition of Resv to a high-fat diet
ameliorates arterial wall inflammation and other arterial markers
associated with aging (Pearson et al., 2008). Further, in apolipo-
protein E-deficient (apo E/) mice, a model of atherosclerosis
with very high levels of circulating cholesterol, dietary supple-
mentation of Resv leads to improvement of lipid profile, accom-
panied by the prevention of intimal lesion formation and inhibition
of HMG-CoA reductase to decrease cholesterol formation (Do
et al., 2008). In pig models, Resv also improves myocardial
perfusion, regional contractility, and decreases oxidative stress
(Elmadhun et al., 2013). We have recently reported that Resv184 Cell Metabolism 20, 183–190, July 1, 2014 ª2014 Elsevier Inc.promotes metabolic and inflammatory adaptations in visceral
white adipose tissue (Jimenez-Gomez et al., 2013) and prevents
pancreatic b cell dedifferentiation (Fiori et al., 2013) of rhesus
monkeys on a high-fat, high-sucrose (HFS) diet. In the present
study, the hypothesis tested that HFS will induce arterial wall
inflammation driven by oxidative stress and cause deleterious in-
crease in central arterial wall stiffness, manifest as an increased
PWV and that these effects will be ameliorated by the addition of
Resv to the HFS in a clinically relevant nonhuman primate (NHP)
model of metabolic disease.
RESULTS AND DISCUSSION
Baseline characteristics of the NHPs comprised in this study
while on a standard diet (SD) are detailed in Table S1 available
online. A 2 year HFS diet in adult (7–13 years) male Macaca
mulatta caused an increase in body weight, an elevation in
plasma cholesterol, and an 40% increase in aortic PWV—
an index of central arterial stiffness. Daily dietary supplementa-
tion with Resv (80 mg for first year and 480 mg for the second
year) prevented the increase in PWV in HFS-fed monkeys (Fig-
ure 1A). The effect on PWV was most profound at 12 months
when the differences between HFS-fed and those supple-
mented with Resv (HFS+R) was 38% (p < 0.05). The gradual
increase in PWV during the second year could be due to the
HFS diet overwhelming the system; alternatively, the higher
dose of Resv may elicit side-effects and offer lower health
benefits (Mukherjee et al., 2010). Despite preventing the HFS-
induced increase in PWV, Resv had no effect on blood pres-
sure (Figure 1B), body weight (Figure 1C), serum cholesterol
(Figure 1D), or total low density lipoprotein (not shown) in linear
mixed model analyses of paired data. Serum levels of both
intercellular adhesion molecule 1 (ICAM) and macrophage in-
flammatory protein 1 (MIP-1), markers of arterial wall inflamma-
tion, increased during the 2 year study in all groups and was
not affected by Resv (not shown). Thus, these typical clinically
measured risk factors for CV disease did not relate to events
occurring within the arterial wall that lead to the reduction in
PWV by the addition of Resv. Furthermore, the size and weight
of the heart and gross morphometric measurements of aortic
remodeling did not vary whether monkeys were fed a HFS or
HFS+R diet (Table S2).
Microscopic morphometric analyses of immunolabeled
aortic cross-sections were performed to determine whether
Resv could prevent the signature of inflammation within the
arterial wall (Figure 2; Table S2). HFS diet induced monocyte/
macrophage infiltration (Figure 2A), endothelial cell loss (Fig-
ure 2B), and enhanced staining for fat deposition and calcifica-
tion (Figures 2C and 2D); furthermore, ICAM-1, vascular cell
adhesion molecule 1 (VCAM-1), and monocyte chemoattrac-
tant protein-1 (MCP-1) immunostaining was also increased in
aortic cross-sections of HFS-fed animals, but normalized by
Resv supplementation (Figures 2E and 2F) despite no effect
on serum lipid profile or circulatory markers of inflammation.
When compared to SD-fed controls, aortic homogenates
from HFS-fed cohort exhibited significantly higher levels of
the stable lipid peroxidation marker, 4-hydroxynonenal (4-
HNE), and caspase 3 activity, which were reversed by Resv
(Figure 2G). Thus, the antioxidant and antiapoptotic response
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phenol to preserve vascular health (Ungvari et al., 2007;
Kaneko et al., 2011).
Monocyte adhesion to human coronary artery endothelial
cells (CAECs) is a key initiating event of arterial wall inflamma-
tion associated with metabolic disease. To ascertain whether
Resv could prevent the HFS-mediated initiation of inflammation
at the monocyte-endothelial cell interface, we assessed the
leukocyte adhesion properties of CAECs after a 24 hr incubation
with medium containing 10% serum from monkeys on experi-
mental diets for 2 years. Strikingly, medium supplementation
with HFS+R serum significantly reduced HFS serum-mediated
increase in PMA-activated human monocytic THP-1 cell adhe-
sion onto confluent monolayer of human CAECs (p < 0.01, Fig-
ure 2H). As a measure of the antiinflammatory action of Resv,
we determined the activation status of NF-kB in human CAECs
treated either with SD, HFS, or HFS+Rmonkey serum (Figure 2I).
The increase in NF-kB promoter activity in response to HFS
monkey serum (9.28 ± 2.80-fold versus SD serum, p = 0.017)
was reduced by 60% in cells treated with HFS+R serum
(p = 0.025). These data suggest that Resv suppresses NF-kB
transcriptional activity to block induction of endothelial genes
implicated in leukocyte recruitment and transmigration as well
as tissue remodeling (Csiszar et al., 2012; Tuttolomondo et al.,
2012).
Activation of the nuclear factor-E(2)-related factor-2 (Nrf2)
pathway improves vascular function in patients with risk of
vascular events through upregulated expression of genes that
contain antioxidant response elements in their promoters (Car-
rizzo et al., 2013). Nrf2 mRNA levels were significantly higher in
human CAECs incubated with HFS+R serum, but not in HFS
serum-treated cells (Figure 2J); moreover, expression of Nrf2
target genes, heme oxygenase-1, and gamma-glutamylcysteine
synthetase, was also upregulated by HFS+R serum, consistent
with previous reports in the NHP animal model (Ungvari et al.,
2011). Thus, a 2 year consumption of Resv may confer athero-
protective effects to the vascular endothelium of HFS-fed mon-
keys via Nrf2 activation.
To identify genes that are key components of the antioxidative
and antiinflammatory pathways of Resv, we performed cDNA
microarray analysis of thoracic aorta. The analysis revealed the
expression of 217 gene sets whose levels were significantly
altered in HFS and HFS+R cohorts based on unbiased gene
ontology (GO) annotations. Of these, 106 gene sets were shared
between the two cohorts (Figure 3A) with all, but one gene set,
exhibiting a reciprocal pattern of expression (Figure 3B). Among
the top upregulated GO annotations for HFS+R versus HFSwere
‘‘fatty acid metabolic process,’’ ‘‘protein catabolic processes,’’
‘‘stress response.’’ and ‘‘mitochondrion.’’ The most highly upre-
gulated gene in the aorta of HFS+R with respect to HFS was
DHCR24, followed by FBN2, MED1, and SNIP1, while the most
downregulated gene was GAS6 (Figure 3C). DHCR24/seladin-
1 encodes a multifunctional enzyme that not only scavenges
H2O2 but also is involved in cholesterol synthesis (Lu et al.,
2008). GAS6 plays a key role in vascular remodeling and calcifi-
cation of vascular smoothmuscle (Konishi et al., 2004; Son et al.,
2007). The expression of selected genes from the microarray
analyses was verified using quantitative RT-PCR analysis (Fig-
ure 3D). Significant changes in GO terms and gene expressionlevels shared between the HFS and HFS+R cohorts are
compiled in Tables S3A and S3B. Expression of gene sets rele-
vant to arterial inflammation that were altered by the experi-
mental diets were: the ‘‘interleukin receptor activity,’’ ‘‘activation
of NF-kB transcription,’’ and ‘‘nitric oxide biosynthetic process.’’
Of significance, Resv supplementation reversed the HFS-
induced reduction inNOS3 expression, which encodes endothe-
lial nitric oxide synthase (eNOS), consistent with recent preclini-
cal studies showing that Resv upregulates eNOS activity
to enhance the production/bioavailability of NO and subse-
quent endothelium-dependent vasodilation (Carrizzo et al.,
2013).Moreover, HFS feeding coordinately regulated expression
of genes implicated in matrix foundation structure and function
and arterial remodeling, which, for the most part, was reversed
by Resv supplementation (Figure S1). Thus, Resv may have
beneficial effects on CV health by evoking effective protection
against diet-induced activation of multiple routes that link inflam-
mation to arterial stiffness. The raw data file and the filtered,
normalized results are available online in the Gene Expression
Omnibus, accession number GSE45927.
To assess molecular signatures consistent with improved
vascular health following Resv supplementation, vascular
smoothmuscle (VSM) cells from themonkey aorta were isolated,
placed in primary culture and thenwere subjected to quantitative
proteomics by stable isotope labeling with amino acids (SILAC)
combined with LC-MS/MS, as previously reported (Park et al.,
2012). Of the 750 proteins identified, expression of 121 proteins
significantly differed in either the HFS and/or HFS+R compared
to SD (Table S3C). GO Term annotation and other Bioinformatic
tools (e.g., KEGG signaling pathway, WikiPathways, and
PathwayCommons analyses) revealed that the differentially
altered proteins in VSM cells included several proteins involved
in cytoskeletal dynamic regulation, calcium regulation, energy
metabolism, and vascular functionality (Figure S2A; Table S4).
A representative set of seven proteins showed a complex series
of dynamic changes with experimental diets. These included
proteins that were upregulated in the HFS-fed animals, but
became either downregulated with Resv supplementation
(e.g., Serpine1) or normalized to SD controls (e.g., Rock2,
b-catenin [Ctnnb1]); proteins whose expression moved in the
same direction in HFS and HFS+R groups (e.g., caveolin 1
[Cav1], microtubule-associated protein 2 [MAP2]); and proteins
that responded only to Resv (e.g., neuromodulin [GAP43], syn-
aptopodin 2 [SYNPO]) (Table S3C; Figure 4A). Serpine1,
Rock2, and b-catenin are related to VSM cell inflammation
(Satoh et al., 2011; Vykoukal and Davies, 2011; Xiao et al.,
2014) and their expression levels were validated in aortic protein
extracts by western blotting (Figure 4B).
Latent Semantic Indexing (LSI) heatmap analysis (Chadwick
et al., 2011) of the 121-protein data set affected by diet demon-
strated that nineteen proteins were implicitly involved in interre-
lated functional networks associated with vascular inflammation
and protection, regeneration, and development (Figure S2B).
Aortic VSM cells exhibited higher levels of NOV (CCN family
member 3), among other proteins, when comparing HFS to
either SD or HFS+R cohort (Figure 4C). NOV is a potent inhibitor
of vascular repair program (Shimoyama et al., 2010). Several
proteinmarkers of endothelial dysfunction that were upregulated
in response to HFS were found to be normalized to SD levels byCell Metabolism 20, 183–190, July 1, 2014 ª2014 Elsevier Inc. 185
(legend on next page)
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Figure 3. Resveratrol Supplementation
Reverses Global Transcriptional Effects of
a HFS Diet in Aorta of Rhesus Monkeys
(A) Venn diagram of GO terms significantly
modified by HFS diet versus SD, and HFS+R
versus HFS.
(B) Graphical representation of the significant 106
GO terms shared by HFS- (plotted in blue) and
HFS+R-fed animals (plotted in red). Metabolic and
catabolic processes, stress response, and mito-
chondrion were among the regulated GO terms in
aorta. Full GO term listing is provided in the Sup-
plemental Information.
(C) Change in expression of select genes between
HFS versus SD and HFS+R versus HFS is de-
picted as Z ratios. List of genes whose expression
in the HFS-fed group was reversed significantly by
Resv supplementation is provided in the Supple-
mental Information.
(D) Validation of the microarray data by quantita-
tive RT-PCR.
See also Figure S1 and Tables S3A and S3B.
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protein 2, and GLIPR2, the former being associated with the
pathogenesis of vascular lesions (Smith et al., 2011). Moreover,
the levels of cytoskeletal regulatory protein Nesprin 2 (SYNE2)
were downregulated by HFS, but restored by Resv supplemen-
tation to levels that were even higher than in VSM from SD con-
trols (Figure 4C). HFS increased expression of transglutaminase
2 (TGM2), an arterial calcification-related protein that is positivelyFigure 2. Resveratrol Supplementation Retards the Adverse Molecular and Cellular Events wit
HFS Diet and CAEC Incubation with Serum from HFS+R Serum Decreases Monocyte Adhesion
(A) Photomicrographs (3400) of the paraffin sections after immunostaining for CD68, a marker of monocyte
mined by 3,30-diaminobenzidine [DAB]); the average density of CD68-stained area/field/cross-section (right p
HFS+R, n = 10.
(B) Photomicrographs (3400) of paraffin sections after immunostaining for CD31, amarker of endothelial cells
cells normalized by the circumference (right panel). *p < 0.05 versus HFS. SD, n = 4; HFS, n = 10; HFS+R, n
(C) Photomicrographs (3400) of frozen sections after Oil O Red staining (left panel); the density of lipid de
versus HFS. SD, n = 4; HFS, n = 10; HFS+R, n = 10.
(D) Photomicrographs (3400) of frozen sections after Alizarin red staining (left panel); the density of calci
versus HFS.
(E) Photomicrographs (3400) of frozen sections after immunostaining with antibodies for the proinflammato
(F) Grade average for ICAM-1, VCAM-1, and MCP-1 immunostaining as well as their summation (defined as
within the intimal and medial compartment. SD, n = 4; HFS, n = 10; HFS+R, n = 10. *p < 0.05, **p < 0.01. Da
(G) 4-HNE content and caspase 3 activity in aorta. SD, n = 3; HFS, n = 9; HFS+R, n = 9. *p < 0.05. Data are
(H) Monocyte adhesion assay in human coronary artery endothelial cells (CAECs) cultured for 24 hr with 1
monkeys. SD, n = 3; HFS, n = 9; HFS+R, n = 10. *p < 0.05. Data are mean ± SEM for all graphs.
(I) NF-kB reporter assayswere initiated after a 24 hr incubation of humanCAECswith HFSmonkey serum. SD,
mean ± SEM for all graphs.
(J) Expression of Nrf2,HO1, andGCLCmRNA in human CAECs was determined by quantitative RT-PCR anal
HFS+R monkey serum were normalized to SD serum. SD, n = 3; HFS, n = 9; HFS+R, n = 10. *p < 0.05. Data
See also Table S2.
Cell Metabolism 20, 183associated with hypertension and athero-
sclerosis (Johnson et al., 2008; Matlung
et al., 2012) and crosslinking of extracel-
lular matrix proteins (Bakker et al., 2008;
Santhanam et al., 2010). This upregula-
tion of TGM2 protein level and activity
in response to HFS was restored to con-trol levels in VSM cells from the HFS+R cohort (Figures 4C, 4D,
and S3). Consistent with the established effects of NO bioavail-
ability on TGM2 regulation (Santhanam et al., 2010), we propose
that Resv supplementation offers endothelial cell protection
against diet-induced metabolic stress partly though TGM2
signaling.
In summary, we provide data about functional and morpho-
metricmeasurements in nonhuman primates, aswell as genomichin the Aortic Wall of Rhesus Monkeys on a
/macrophage cells (left panel) (brown color deter-
anel). *p < 0.05 versus HFS. SD, n = 4; HFS, n = 10;
(left panel); the number of CD31-stained endothelial
= 10.
position/field/cross-section (right panel). *p < 0.05
fication/field/cross-section (right panel). *p < 0.05
ry molecules ICAM-1, VCAM-1, and MCP-1.
local proinflammatory profile) of cells plus matrix
ta are mean ± SEM for all graphs.
mean ± SEM for all graphs.
0% serum from SD-, HFS- or HFS+R-fed rhesus
n = 3; HFS, n = 9; HFS+R, n = 10. *p < 0.05. Data are
ysis. The effects of a 24 hr incubation with HFS and
are mean ± SEM for all graphs.
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Figure 4. Resveratrol Supplementation Restores the Conversion of ‘‘Multidimensional’’ Protein Network of the Cytoskeletal Dynamics and
Vascular Functionality
(A) Log2-transformed SILAC expression ratio data for proteins extracted and identified in primary cultures of vascular smooth muscle (VSM) from rhesus monkey
on SD, HFS, and HFS+R diet. These proteins were selected due to their implicit textual association with vascular functionality (see Supplemental Information for
additional information). The proteins identified demonstrated a significantly altered degree of expression regulation in either the HFS (blue squares) or HFS+R (red
circle) cohort (p < 0.05). Nonsignificant expression changes are identified for the HFS cohort with light blue squares and for the HFS+R cohort with pink circles.
(B) Western blot validation of several proteins identified with SILAC. Representative western blot panels display the expression profile from a set of SD, HFS, and
HFS+R-fed monkeys. The associated scatterplot histograms indicate the degree of individual animal variation in expression, as well as the significant p value
(t test) for HFS or HFS+R compared to SD.
(C) The effects of Resv and HFS diet treatments on 19 ‘‘multidimensional’’ proteins identified from multiple bioinformatic interpretation (GO-bp, KEGG,
WikiPathways, PathwayCommons). These proteins isolated from VSM extracts were associated with all the interrogator terms.
(D) TGM2 expression in primary culture of rhesus monkey VSM cells was measured using western blot and expression levels were normalized to GAPDH.
See also Figures S2 and S3 and Tables S3C and S4.
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cells, which establish that a 2 year dietary supplementation of
Resv has a marked effect to reduce central arterial wall inflam-
mation that underlie arterial wall stiffening, which accompanies
chronic metabolic stress, advancing age, and age-associated
diseases (i.e., atherosclerosis, hypertension and diabetes) that188 Cell Metabolism 20, 183–190, July 1, 2014 ª2014 Elsevier Inc.have become rampant within Western society. Thus, dietary
resveratrol at doses achievable in humans can safely reduce
many of the negative consequences of excess caloric intake,
and it may hold promise as a therapy to ameliorate increases
in PWV and metabolic stress-induced factors that accelerate
CV disease.
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Animals and Diets
During baseline assessments, all monkeys weremaintained on a commercially
available closed formula monkey chow (TestDiet 5038, Purina Mills). After
baseline assessment, the 24 male rhesus monkeys were quasi-randomized
into one of three groups: an HFS diet (n = 10), HFS+R (n = 10), or remaining
on the healthy SD (n = 4). The SD was a purified biscuit consisting of 13% of
kcal in fat and <5% sucrose by weight. The HFS diet was a specially formu-
lated purified ingredient diet with 42% of kcal in fat and 27% sucrose by
weight (Harlan, Teklad); additional details are provided in the Supplemental
Information. The monkeys were gradually switched to the HFS diet over a
3 week period. All groups received two meals per day of the specified diet in
allotments that represent ad libitum feeding, yet consumption was isocaloric
across groups. Resveratrol was supplied by DSM Nutritional Products.
HFS+R monkeys received 40 mg Resv twice a day for the first year that was
increased to 240 mg twice a day during the second year. The HFS and SD
monkeys received a placebo treat. All procedures were approved by the Ani-
mal Care and Use Committee of the NIA Intramural Research Program.
Gene Expression
Microarray and quantitative RT-PCR techniques were carried out according to
standard procedures to determine the effects of Resv on gene expression in
rhesus monkey aorta. Full methodological details are described in Supple-
mental Experimental Procedures. The primer sequences used for quantitative
RT-PCR are summarized in Table S5.
Determination of 4-HNE Content and Caspase-3 Activity in Aorta
Samples
Frozen aorta samples were pulverized and aliquots were homogenized in
assay-specific lysis buffers. Tissue content in 4-HNE was assessed using
the OxiSelect HNE-His Adduct ELISA kits (Cell BioLabs).
Caspase-3 activity, a useful marker of apoptosis, was measured using the
Caspase-Glo 3/7 assay system (Promega), as previously described (Ungvari
et al., 2007). Luminescence intensitywasmeasuredusingan InfiniteM200plate
reader (Tecan US) and was normalized to the sample protein concentration.
Effect of Monkey Serum on Human CAECs
Primary human CAECs (Cell Applications) were cultured in MesoEndo Endo-
thelial Cell Growth Medium (Cell Applications) supplemented with 10% fetal
calf serum and 1% antibiotics (GIBCO) until the time of treatment. For treat-
ment, cells (passage 4 and up) were incubated for 24 hr in serum-free medium
supplemented with serum collected fromSD, HFS, and HFS+Rmonkeys (10%
final concentration). Monocyte adhesion assay and quantitative RT-PCR anal-
ysis were carried out (see Supplemental Information for additional details).
Transient Transfection and NF-kB Reporter Gene Assay
Transcriptional activity of NF-kB was tested in monkey serum-treated CAECs
by a reporter gene assay as described (Ungvari et al., 2011). A NF-kB reporter
comprised of an NF-kB response element upstream of firefly luciferase (NF-
kB-Luc, Stratagene) together with a Renilla luciferase plasmid under the con-
trol of CMV promoter was used in this assay.
Statistical Analyses
PWV, body weight, and serum cholesterol repeated-measures data were
analyzed using linear mixed-effects models. A group or group 3 time interac-
tion were considered statistically significant at p % 0.05. For histochemical
analysis, a one-way ANOVA was done to compare mean values for the SD,
HFS, and HFS+R groups. Pairwise comparisons were made using the Bonfer-
roni multiple comparison test. Data are presented as mean ± SEM. In each
western blot histogram, data represent the means ± SE. Statistical analyses
(Student’s t test) were performed using GraphPad Prism (GraphPad Software).
p% 0.05 was considered statistically significant.
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The Gene Expression Omnibus accession number for the data reported in this
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Supplemental Information includes Supplemental Experimental Procedures,
three figures, and five tables and can be found with this article online at
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